187 related articles for article (PubMed ID: 18951537)
1. UPDRS activity of daily living score as a marker of Parkinson's disease progression.
Harrison MB; Wylie SA; Frysinger RC; Patrie JT; Huss DS; Currie LJ; Wooten GF
Mov Disord; 2009 Jan; 24(2):224-30. PubMed ID: 18951537
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW
Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191
[TBL] [Abstract][Full Text] [Related]
3. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
LeWitt P; Oakes D; Cui L
Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.
Reichmann H; Boas J; Macmahon D; Myllyla V; Hakala A; Reinikainen K;
Acta Neurol Scand; 2005 Jan; 111(1):21-8. PubMed ID: 15595934
[TBL] [Abstract][Full Text] [Related]
5. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G
Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196
[TBL] [Abstract][Full Text] [Related]
6. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
7. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
8. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
9. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
[TBL] [Abstract][Full Text] [Related]
10. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
11. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome.
Desaloms JM; Krauss JK; Lai EC; Jankovic J; Grossman RG
J Neurosurg; 1998 Aug; 89(2):194-9. PubMed ID: 9688112
[TBL] [Abstract][Full Text] [Related]
12. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
[TBL] [Abstract][Full Text] [Related]
13. Continuous quantitative monitoring of physical activity in Parkinson's disease patients by using wearable devices: a case-control study.
Cai G; Huang Y; Luo S; Lin Z; Dai H; Ye Q
Neurol Sci; 2017 Sep; 38(9):1657-1663. PubMed ID: 28660562
[TBL] [Abstract][Full Text] [Related]
14. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease - retrospective evaluation of postoperative independence in pursuing daily activities.
Yamada K; Hamasaki T; Kuratsu J
Parkinsonism Relat Disord; 2009 Dec; 15(10):746-51. PubMed ID: 19481492
[TBL] [Abstract][Full Text] [Related]
15. Minimal clinically important change on the unified Parkinson's disease rating scale.
Schrag A; Sampaio C; Counsell N; Poewe W
Mov Disord; 2006 Aug; 21(8):1200-7. PubMed ID: 16673410
[TBL] [Abstract][Full Text] [Related]
16. Contribution of aging to the severity of different motor signs in Parkinson disease.
Levy G; Louis ED; Cote L; Perez M; Mejia-Santana H; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Marder K
Arch Neurol; 2005 Mar; 62(3):467-72. PubMed ID: 15767513
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal metric properties of disability rating scales for Parkinson's disease.
Martinez-Martin P; Prieto L; Forjaz MJ
Value Health; 2006; 9(6):386-93. PubMed ID: 17076869
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
19. Selegiline slows the progression of the symptoms of Parkinson disease.
Pålhagen S; Heinonen E; Hägglund J; Kaugesaar T; Mäki-Ikola O; Palm R;
Neurology; 2006 Apr; 66(8):1200-6. PubMed ID: 16540603
[TBL] [Abstract][Full Text] [Related]
20. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
van Hilten JJ; van der Zwan AD; Zwinderman AH; Roos RA
Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
